Innovaderm Will be at AAD 2024 in San Diego!
2024-02-20
Join us at the AAD Annual Meeting in San Diego from March 8th - 12th, 2024!
Connect with us now and meet with our teams from the following departments:
- Business Development
- Clinical Operations
- Project Management
- Vendor Management
- Early Phase & Translational Research
- Scientific & Medical Affairs
- Site Selection
Book some time with your dermatology and medical aesthetics experts!
Innovaderm's Full Involvement at AAD
Our very own founder and CEO, Dr. Robert Bissonnette, contributed to a series of e-Poster, which will be publicly available in the AAD online viewing portal and on-site at the viewing stations. They will also be published online via the JAAD supplement in Fall 2024:
- Tapinarof Cream 1% Once Daily: Interim Analysis of ADORING 3 Phase 3 Long-term Extension Trial in Adults and Children Down to 2 Years of Age with Atopic Dermatitis
- Efficacy and Safety of Delgocitinib Cream in Adults with Moderate-to-Severe Chronic Hand Eczema: Pooled Results of the Phase 3 DELTA-1 and -2 Trials
- Long-Term Safety Data for Dupilumab in a 5-Year Open-Label Extension Study of Adults With Moderate-to-Severe Atopic Dermatitis
Dr. Bissonnette will also be presenting sessions at the congress:
-
- FRM F089 - Hand and Foot Psoriasis, Dermatitis, and Other Inflammatory Dermatoses - Sunday, March 10| 3:30 PM - 5:30 PM
Innovaderm's 5th Breakfast Event at AAD
Do not miss out on this free & exclusive opportunity to learn from world-renowned KOLs 🔬
On the menu: Scientific presentations on ALOPECIA AREATA, discussions with global industry leaders, a complimentary breakfast, and more. 🥐☕
Claim one of the few remaining spots now!
Newsletter